Biomarkers used in epidemiology were discussed with respect to scientific issues and ethical concerns. Currently used biomarkers were characterized by: the ability to detect xenobiotics at concentrations at the cellular and molecular level; the ability to detect earlier biologic changes presumptive of disease or disease risk; and to identify a detailed continuum of events between an exposure and resultant disease. Biomarkers must be valid, reliable, and practical if they are to enhance cancer epidemiology. Pilot studies should be conducted prior to the primary study when these characteristics have not been demonstrated previously. In order for the marker selected to be a useful one it is important that there be interdisciplinary communication and collaboration. This will also improve the interpretation of the findings, making them more appropriate to the marker under study. To validate a marker for use in a population, attention must be paid to issues of background prevalence, sample size, natural history, persistence, variability, confounding factors, and predictive value. Practical features such as subject preparation, access to and storage of specimens, and costs must be clarified. The use of biologic markers in epidemiologic studies will ultimately depend on how well these markers increase the ability to reduce misclassification, provide for better understanding of exposure and disease associations, and increase the number of opportunities to prevent the disease from occurring. Implications ranged from uncertainty about the marker's meaning to societal responses to groups expressing abnormal marker frequencies.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.